Pharmaceutical Supply – Meloxicam Tablets (NDC-Specific)

The contract entails the supply of FDA-approved Meloxicam tablets in 6,000 bottles, each labeled under specific NDC codes, for delivery to a U.S. Navy vessel. All product must comply with the labeling, packaging, and regulatory standards required by the Defense Logistics Agency for procurement, ensuring full alignment with federal pharmaceutical guidelines and military specifications. The transaction is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and is managed by the Department of Defense through the Defense Logistics Agency. Delivery must be completed to the designated Navy vessel location, with no alternative delivery points permitted. The product must be sourced, manufactured, and documented in strict conformity with FDA regulations and DLA procurement protocols, including accurate NDC identification, proper shelf-life verification, and traceable batch documentation. The contract was posted on May 31, 2026, and is tied to the specific award and delivery identifiers SPE2DX25D9900 and SPE2DP26F6059, with performance details governed by official DLA contracting procedures.